Evidence map›Paper›PMID 29495461›Full record

ReviewMedical sciences (Basel, Switzerland)2018

Artemisinin and Its Synthetic Derivatives as a Possible Therapy for Cancer.

Enrique Konstat-Korzenny, Jorge Alberto Ascencio-Aragón, Sebastian Niezen-Lugo, Rosalino Vázquez-López

Open access · goldAbstract readReview
In one paragraph

Review in Medical sciences (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 84 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The Beneficial Use ofAnimals : an open access journal from MDPI · 2025
    Review
  5. Review
  6. Supercritical COBiotechnology notes (Amsterdam, Netherlands) · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Oxidative medicine and cellular longevity · 2022
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Silver Nanoparticles Derived byInternational journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Enrique Konstat-KorzennyDepartamento de Microbiología del Centro de Investigación en Ciencias de la Salud (CICSA) Facultad de Ciencias de la Salud, Universidad Anáhuac México Campus Norte. Av. Universidad Anáhuac 46 Col. Lomas Anáhuac Huixquilucan, Estado de México 52786, México. enriquekonstat@gmail.com.ORCID 0000-0002-1297-3112
Jorge Alberto Ascencio-AragónDepartamento de Microbiología del Centro de Investigación en Ciencias de la Salud (CICSA) Facultad de Ciencias de la Salud, Universidad Anáhuac México Campus Norte. Av. Universidad Anáhuac 46 Col. Lomas Anáhuac Huixquilucan, Estado de México 52786, México. jorgeascarg@gmail.com.
Sebastian Niezen-LugoDepartamento de Microbiología del Centro de Investigación en Ciencias de la Salud (CICSA) Facultad de Ciencias de la Salud, Universidad Anáhuac México Campus Norte. Av. Universidad Anáhuac 46 Col. Lomas Anáhuac Huixquilucan, Estado de México 52786, México. sebastiannl7@hotmail.com.
Rosalino Vázquez-LópezDepartamento de Microbiología del Centro de Investigación en Ciencias de la Salud (CICSA) Facultad de Ciencias de la Salud, Universidad Anáhuac México Campus Norte. Av. Universidad Anáhuac 46 Col. Lomas Anáhuac Huixquilucan, Estado de México 52786, México. rosalino.vazquez@anahuac.mx.ORCID 0000-0002-1982-7329
Universidad Anáhuac · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To assess the possibility of using the antimalarial drug artemisinin and its synthetic derivatives as antineoplastic drugs. A Pubmed and Google Scholar (1983-2018) search was performed using the terms artemisinin, cancer, artesunate and

Indexed as

artemisinincancermalaria

Identifiers

PMID29495461
PMCPMC5872176
OpenAlexW2792422505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.